Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.
Elena
E
Maldi
Cristina
C
Travelli
Antonio
A
Caldarelli
Nicolò
N
Agazzone
Sara
S
Cintura
Ubaldina
U
Galli
Maria
M
Scatolini
Paola
P
Ostano
Benedetta
B
Miglino
Giovanna
G
Chiorino
Renzo
R
Boldorini
Armando A
AA
Genazzani
D000178:Acrylamides / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*; D054409:Nicotinamide Phosphoribosyltransferase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*
D000178:Acrylamides; D004791:Enzyme Inhibitors; C480543:N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide; D010880:Piperidines; D054409:Nicotinamide Phosphoribosyltransferase